Free Access
Vet. Res.
Volume 32, Number 3-4, May-August 2001
Mechanisms of resistance to antibiotics in animal and zoonotic pathogens
Page(s) 311 - 321
How to cite this article Vet. Res. (2001) 311-321
  1. Aarestrup F.M., Occurrence, selection and spread of resistance to antimicrobial agents used for growth promotion in Denmark, APMIS 108 Suppl. 101 (2000) 1-48 [PubMed].
  2. Aarestrup F.M., Nielsen E.M., Madsen M., Engberg J., Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark, Antimicrob. Agents Chemother. 41 (1997) 2244-2250 [PubMed].
  3. Aarestrup F.M., Agerso Y., Gerner-Smidt P., Madsen M., Jensen L.B., Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark, Diagn. Microbiol. Infect. Dis. 37 (2000) 127-137 [CrossRef] [PubMed].
  4. Anonymous, DANMAP 99 - Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark, July 2000, ISSN 1600-3032.
  5. Barthélémy P., Autissier D., Gerbaud G., Courvalin P., Enzymic hydrolysis of erythromycin by a strain of Escherichia coli. A new mechanism of resistance, J. Antibiot. (Tokyo) 37 (1984) 1692-1696 [PubMed].
  6. Bischoff K., Jacob J., The sat4 streptothricin acetyltransferase gene of Campylobacter coli: its distribution in the environment and use as epidemiological marker, Zentralbl. Hyg. Umweltmed. 198 (1996) 241-257 [PubMed].
  7. Blaser M.J., Campylobacter species, in: Mandell G.L., Bennett J.E., Dolin R. (Eds.), Principles and practice of infectious diseases (4th ed.), Churchill Livingstone Inc., New York, 1995, pp. 1948-1956.
  8. Bottcher I., Jacob J., The occurrence of high-level streptothricin resistance in thermotolerant campylobacters isolated from the slurry of swine and the environment, Zentralbl. Bakteriol. 277 (1992) 467-473 [PubMed].
  9. Bradbury W.C., Munroe L.G., Occurrence of plasmids and antibiotic resistance among Campylobacter jejuni and Campylobacter coli isolated from healthy and diarrheic animals, J. Clin. Microbiol. 22 (1985) 339-346 [PubMed].
  10. Buu-Hoi A., Le Bouguenec C., Horaud T., Genetic basis of antibiotic resistance in Aerococcus viridans, Antimicrob. Agents Chemother. 33 (1989) 529-534 [PubMed].
  11. Cabrita J., Rodrigues J., Braganca F., Morgado C., Pires I., Goncales A.P., Prevalence, biotypes, plasmid profile and antimicrobial resistance of Campylobacter isolated from wild and domestic animals from Northeast Portugal, J. Appl. Bacteriol. 73 (1992) 279-285 [PubMed].
  12. Derbise A., Aubert S., El Solh N., Mapping the regions carrying the three contiguous antibiotic resistance genes aadE, sat4, and aphA-3 in the genomes of staphylococci, Antimicrob. Agents Chemother. 41 (1997) 1024-1032 [PubMed].
  13. Endtz H.P., Ruijs G.J., van Klingeren B., Jansen W.H., van der Reyden T., Mouton R.P., Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine, J. Antimicrob. Chemother. 27 (1991) 199-208 [CrossRef] [PubMed].
  14. Engberg J., Andersen S., Skov R., Aarestrup F.M., Gerner-Smidt P., Comparison of two agar dilution methods and three agar diffusion methods including the Etest for antibiotic susceptibility testing of thermophilic Campylobacter species, Clin. Microbiol. Infect. 5 (1999) 580-584 [PubMed].
  15. Engberg J., Aarestrup F.M., Taylor D., Gerner-Smidt P., Nachamkin I., Quinolone and macrolide resistance in Campylobacter jejuni and coli: Resistance mechanisms and trends in human isolates, Emerg. Infect. Dis. 7 (2001) 24-34 [PubMed].
  16. Gaudreau C., Gilbert H., Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada, Antimicrob. Agents Chemother. 42 (1998) 2106-2108 [PubMed].
  17. Gibreel A., Skold O., High-level resistance to trimethoprim in clinical isolates of Campylobacter jejuni by acquisition of foreign genes (dfr1 and dfr9) expressing drug-insensitive dihydrofolate reductases, Antimicrob. Agents Chemother. 42 (1998) 3059-3064 [PubMed].
  18. Gibreel A., Skold O., Sulfonamide resistance in clinical isolates of Campylobacter jejuni: mutational changes in the chromosomal dihydropteroate synthase, Antimicrob. Agents Chemother. 43 (1999) 2156-2160 [PubMed].
  19. Gibreel A., Skold O., An integron cassette carrying dfr1 with 90-bp repeat sequences located on the chromosome of trimethoprim-resistant isolates of Campylobacter jejuni, Microb. Drug Resist. 6 (2000) 91-98 [PubMed].
  20. Gibreel A., Sjogren E., Kaijser B., Wretlind B., Skold O., Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC, Antimicrob. Agents Chemother. 42 (1998) 3276-3278 [PubMed].
  21. Goodman L.J., Trenholme G.M., Kaplan R.L., Segreti J., Hines D., Petrak R., Nelson J.A., Mayer K.W., Landau W., Parkhurst G.W., Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults, Arch. Intern. Med. 150 (1990) 541-546 [CrossRef] [PubMed].
  22. Hampele I.C., D'Arcy A., Dale G.E., Kostrewa D., Nielsen J., Oefner C., Page M.G., Schonfeld H.J., Stuber D., Then R.L., Structure and function of the dihydropteroate synthase from Staphylococcus aureus, J. Mol. Biol. 268 (1997) 21-30 [CrossRef] [PubMed].
  23. Hariharan H., Wright T., Long J.R., Isolation and antimicrobial susceptibility of Campylobacter coli and Campylobacter jejuni from slaughter hogs, Microbiologica 13 (1990) 1-6 [PubMed].
  24. Hoge C.W., Gambel J.M., Srijan A., Pitarangsi C., Echeverria P., Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years, Clin. Infect. Dis. 26 (1998) 341-345 [PubMed].
  25. Hollingshead S., Vapnek D., Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenylyltransferase, Plasmid 13 (1985) 17-30 [CrossRef] [PubMed].
  26. Jacobs-Reitsma W.F., Koenraad P.M., Bolder N.M., Mulder R.W., In vitro susceptibility of Campylobacter and Salmonella isolates from broilers to quinolones, ampicillin, tetracycline, and erythromycin, Vet. Q. 16 (1994) 206-208 [PubMed].
  27. Jensen L.B., Aarestrup F.M., Macrolide resistance in Campylobacter coli of animal origin in Denmark, Antimicrob. Agents Chemother. 45 (2001) 371-372 [CrossRef] [PubMed].
  28. Kaneuchi C., Ashihara M., Sugiyama Y., Imaizumi T., Antimicrobial susceptibility of Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis from cats, dogs, pigs, and seagulls, Jpn. J. Vet. Sci. 50 (1988) 685-691.
  29. Lachance N., Gaudreau C., Lamothe F., Larivière L.A., Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents, Antimicrob. Agents Chemother. 35 (1991) 813-818 [PubMed].
  30. Lachance N., Gaudreau C., Lamothe F., Turgeon F., Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents, Antimicrob. Agents Chemother. 37 (1993) 1174-1176 [PubMed].
  31. Manavathu E.K., Hiratsuka K., Taylor D.E., Nucleotide sequence analysis and expression of a tetracycline-resistance gene from Campylobacter jejuni, Gene 62 (1988) 17-26 [CrossRef] [PubMed].
  32. Maskell J.P., Sefton A.M., Hall L.M., Mechanism of sulfonamide resistance in clinical isolates of Streptococcus pneumoniae, Antimicrob. Agents Chemother. 41 (1997) 2121-2126 [PubMed].
  33. Moon K.-H., Shin C.K., Kim W.K., Im S.H., Linkage of kanamycin resistance gene with the streptothricin resistance gene in Staphylococcus aureus SA2, J. Microbiol. Biotechnol. 6 (1996) 219-220.
  34. Munroe D.L., Prescott J.F., Penner J.L., Campylobacter jejuni and Campylobacter coli serotypes isolated from chickens, cattle, and pigs, J. Clin. Microbiol. 18 (1983) 877-881 [PubMed].
  35. Nachamkin I., Engberg J., Aarestrup F.M., Diagnosis and antimicrobial susceptibility of Campylobacter species, in: Nachamkin I., Blaser M.J. (Eds.), Campylobacter (2nd ed.), ASM Press, Washington D.C., 2000, pp. 45-66.
  36. National Committee for Clinical Laboratory Standards (NCCLS), Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M7-A4, National Committee for Clinical Laboratory Standards, Villanova, Pa., 2000.
  37. Nielsen E.M., Engberg J., Madsen M., Distribution of serotypes of Campylobacter jejuni and C. coli from Danish patients, poultry, cattle and swine, FEMS Immunol. Med. Microbiol. 19 (1997) 47-56 [PubMed].
  38. On S.L.W., Nielsen E.M., Engberg J., Madsen, M., Validity of SmaI-defined genotypes of Campylobacter jejuni examined by SalI, KpnI, and BamHI polymorphisms: evidence of identical clones infecting humans, poultry, and cattle, Epidemiol. Infect. 120 (1998) 231-237 [CrossRef] [PubMed].
  39. Ouellette M., Gerbaud G., Lambert T., Courvalin P., Acquisition by a Campylobacter-like strain of aphA-1, a kanamycin resistance determinant from members of the family Enterobacteriaceae, Antimicrob. Agents Chemother. 31 (1987) 1021-1026 [PubMed].
  40. Owen R.J., Leeton S., Restriction fragment length polymorphism analysis of the flaA gene of Campylobacter jejuni for subtyping human, animal and poultry isolates, FEMS Microbiol. Lett. 176 (1999) 345-350 [PubMed].
  41. Petruccelli B.P., Murphy G.S., Sanchez J.L., Walz S., DeFraites R., Gelnett J., Haberberger R.L., Echeverria P., Taylor D.E., Treatment of traveler's diarrhea with ciprofloxacin and loperamide, J. Infect. Dis. 165 (1992) 557-560 [PubMed].
  42. Pinto-Alphandary H., Mabilat C., Courvalin P., Emergence of aminoglycoside resistance genes aadA and aadE in the genus Campylobacter, Antimicrob. Agents Chemother. 34 (1990) 1294-1296 [PubMed].
  43. Prats G., Mirelis B., Llovet T., Munoz C., Miro E., Navarro F., Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona, Antimicrob. Agents Chemother. 44 (2000) 1140-1145 [CrossRef] [PubMed].
  44. Radstrom P., Swedberg G., Skold O., Genetic analyses of sulfonamide resistance and its dissemination in gram-negative bacteria illustrate new aspects of R plasmid evolution, Antimicrob. Agents Chemother. 35 (1991) 1840-1848 [PubMed].
  45. Rautelin H., Renkonen O.-V., Kosunen T.U., Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland, Antimicrob. Agents Chemother. 35 (1991) 2065-2069 [PubMed].
  46. Reina J., Ros M.J., Serra A., Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients, Antimicrob. Agents Chemother. 38 (1994) 2917-2920 [PubMed].
  47. Rivera M.J., Castillo J., Martin C., Navarro M., Gomez-Lus R., Aminoglycoside-phosphotransferases APH(3')-IV and APH('') synthesized by a strain of Campylobacter coli, J. Antimicrob. Chemother. 18 (1986) 153-158 [CrossRef].
  48. Roberts M.C., Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution, FEMS Microbiol. Rev. 19 (1996) 1-24 [PubMed].
  49. Ruiz J., Goni P., Marco F., Gallardo F., Mirelis B., Jimenez De Anta T., Vila J., Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates, Microbiol. Immunol. 42 (1998) 223-226 [PubMed].
  50. Saenz Y., Zarazaga M., Lantero M., Gastanares M.J., Baquero F., Torres C., Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998, Antimicrob. Agents Chemother. 44 (2000) 267-271 [CrossRef] [PubMed].
  51. Salazar-Lindo E., Sack R.B., Chea-Woo E., Kay B.A., Piscoya I., Leon-Barua R.Y., Early treatment with erythromycin of Campylobacter jejuni associated dysentery in children, J. Pediatr. 109 (1986) 3555-3560.
  52. Sánchez R., Fernández-Baca V., Díaz M.D., Munoz P., Rodríguez-Créxems M., Bouza E., Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides, Antimicrob. Agents Chemother. 38 (1994) 1879-1882 [PubMed].
  53. Shaw K.J., Rather P.N., Hare R.S., Miller G.H., Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes, Microbiol. Rev. 57 (1993) 138-163 [PubMed].
  54. Shaw W.V., Chemical anatomy of antibiotic resistance: chloramphenicol acetyltransferase, Sci. Prog. 76 (1992) 565-580 [PubMed].
  55. Sjøgren E., Lindblom G.B., Kaijser B., Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients, J. Antimicrob. Chemother. 40 (1997) 257-261 [CrossRef] [PubMed].
  56. Skirrow M.B., Blaser M.J., Clinical aspects of Campylobacter infection, in: Nachamkin I., Blaser M.J. (Eds.), Campylobacter (2nd ed.), ASM Press, Washington D.C., 2000, pp. 69-88.
  57. Smith K.E., Besser J.M., Hedberg C.W., Leano F.T., Bender J.B., Wicklund J.H., Johnson B.P., Moore K.A., Osterholm M.T., and the investigation Team, Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998, N. Engl. J. Med. 340 (1999) 1525-1532 [CrossRef] [PubMed].
  58. Smith K.E., Bender J.B., Osterholm M.T., Antimicrobial resistance in animals and relevance to human infections, in: Nachamkin I., Blaser M.J. (Eds.), Campylobacter (2nd ed.), ASM Press, Washington D.C., 2000, pp. 483-495.
  59. Sougakoff W., Papadopoulou B., Nordmann P., Courvalin P., Nucleotide sequence and distribution of gene tetO encoding tetracycline resistance in Campylobacter coli, FEMS Microbiol. Lett. 44 (1987) 153-159.
  60. Sutcliffe J., Grebe T., Tait-Kamradt A., Wondrack L., Detection of erythromycin-resistant determinants by PCR, Antimicrob. Agents Chemother. 40 (1996) 2562-2566 [PubMed].
  61. Swedberg G., Ringertz S., Skold O., Sulfonamide resistance in Streptococcus pyogenes is associated with differences in the amino acid sequence of its chromosomal dihydropteroate synthase, Antimicrob. Agents Chemother. 42 (1998) 1062-1067 [PubMed].
  62. Tajada P., Gomez-Graces J.L., Alos J.I., Balas D., Cogollos R., Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors, Antimicrob. Agents Chemother. 40 (1996) 1924-1925 [PubMed].
  63. Talsma E., Goettsch W.G., Nieste H.L., Schrijnemakers P.M., Sprenger M.J., Resistance in Campylobacter species: increased resistance to fluoroquinolones and seasonal variation, Clin. Infect. Dis. 29 (1999) 845-848 [PubMed].
  64. Taylor D.E., Yan W., Ng L.K., Manavathu E.K., Courvalin P., Genetic characterization of kanamycin resistance in Campylobacter coli, Ann. Inst. Pasteur Microbiol. 139 (1988) 665-676 [CrossRef] [PubMed].
  65. Taylor D.E., Ge Z., Purych D., Lo T., Hiratsuka K., Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations, Antimicrob. Agents Chemother. 41 (1997) 2621-2628 [PubMed].
  66. Tenover F.C., Elvrum P.M., Detection of two different kanamycin resistance genes in naturally occurring isolates of Campylobacter jejuni and Campylobacter coli, Antimicrob. Agents Chemother. 32 (1988) 1170-1173 [PubMed].
  67. Trieber C.A, Taylor D.E., Erythromycin resistance in Campylobacter, in: Abstracts and final program of the 10th international workshop on Campylobacter, Helicobacter and related organisms, Baltimore, MD, University of Maryland School of Medicine, 1999, p. 3.
  68. Trieber C.A., Taylor D.E., Mechanisms of antibiotic resistance in Campylobacter, in: Nachamkin I., Blaser M.J. (Eds.), Campylobacter (2nd ed.), ASM Press, Washington D.C., 2000, pp. 441-454.
  69. Trieu-Cuot P., Arthur M., Courvalin P., Origin, evolution and dissemination of antibiotic resistance genes, Microbiol. Sci. 4 (1987) 263-266 [PubMed].
  70. Van der Auwera P., Scorneaux B., In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam, Antimicrob. Agents Chemother. 28 (1985) 37-40 [PubMed].
  71. Vandamme P., Taxonomy of the family Campylobacteraceae, in: Nachamkin I., Blaser M.J. (Eds.), Campylobacter (2nd ed.), ASM Press, Washington D.C., 2000, pp. 3-26.
  72. Vanhoof R., Goossens H., Coignau H., Stas G., Butzler J.P., Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents, Antimicrob. Agents Chemother. 21 (1982) 990-992 [PubMed].
  73. Wang W.L., Reller L.B., Blaser M.J., Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli, Antimicrob. Agents Chemother. 26 (1984) 351-353 [PubMed].
  74. Wang Y., Taylor D.E., Chloramphenicol resistance in Campylobacter coli: nucleotide sequence, expression, and cloning vetor construction, Gene 94 (1990) 23-28 [CrossRef] [PubMed].
  75. Wang Y., Huang W.M., Taylor D.E., Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations, Antimicrob. Agents Chemother. 37 (1993) 457-463 [PubMed].
  76. Weisblum B., Erythromycin resistance by ribosome modification, Antimicrob. Agents Chemother. 39 (1995) 577-585 [PubMed].
  77. World Health Organization, The medical impact of the use of antimicrobials in food animals, Report of a WHO meeting, 1997.
  78. World Health Organization, WHO global principles for the containment of antimicrobial resistance in animals intended for food. Report of a WHO consultation, 5-9 June, Geneva, Switzerland, 2000.
  79. Yan W., Taylor D.E., Characterization of erythromycin resistance in Campylobacter jejuni and Campylobacter coli, Antimicrob. Agents Chemother. 35 (1991) 1989-1996 [PubMed].
  80. Zilhao R., Papadopoulou B., Courvalin P., Occurrence of the Campylobacter resistance gene tetO in Enterococcus and Streptococcus spp, Antimicrob. Agents Chemother. 32 (1988) 1793-1796 [PubMed].
  81. Zirnstein G., Li Y., Swaminathan B., Angulo F., Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis, J. Clin. Microbiol. 37 (1999) 3276-3280 [PubMed].